Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/2000
08/17/2000WO2000032629A3 Antiviral peptides
08/17/2000WO2000023463A3 Fluorescent dye binding peptides
08/17/2000DE19948867A1 Tumor necrosis factor alpha binding peptide comprises 4-9 amino acids
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000CA2362574A1 Antiangiogenic drugs
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362525A1 Cyclic peptides and aids vaccines
08/17/2000CA2362464A1 A synthetic peptide disturbing intracellular signaling
08/17/2000CA2359785A1 .beta.-secretase enzyme compositions and methods
08/17/2000CA2341348A1 Improved compounds for protein binding
08/17/2000CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response
08/16/2000EP0509080B1 Inhibitors and substrates of thrombin
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
08/16/2000CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
08/16/2000CN1055480C Substitution analogues of magainin peptides
08/16/2000CN1055479C Cardiovascular active polypeptide and its synthesis and medical use
08/15/2000US6103881 GnRH analogs for destroying gonadotrophs
08/15/2000US6103870 CS-1 peptidomimetic, compositions and methods of using the same
08/15/2000US6103698 Useful in treating cancer in a mammal; in combination with paclitaxel and taxotere
08/15/2000US6103697 Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues
08/15/2000US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain
08/15/2000US6103483 Labeling a polypeptide having a truncated portion of a prosaposin molecule, with a light sensitive probe, contacting probe with a sperm sample and exposing to a light source, measuring anount of probe per sperm which reacts with light
08/15/2000US6103231 Antibiotic stalobacins
08/15/2000US6103228 Antibiotic-producing and metabolite-producing bacillus subtilis strain that exhibits insecticidal activity
08/15/2000CA2046601C Production and use of anthelmintic agents and protective immunogens
08/10/2000WO2000046371A1 Tau-conotoxin peptides
08/10/2000WO2000046239A1 Cyclosporin derivatives and method for the production of said derivatives
08/10/2000WO2000046238A1 Volatilizable solid phase supports for compound synthesis
08/10/2000WO2000045831A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000WO2000011020A9 Deoxyhypusine reagent and peptides
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000CA2361612A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025119A1 Histogranin peptide and their analgesic use
08/09/2000EP1025118A1 Spacer peptides and membranes containing same
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/09/2000CN1262688A Integrin binding peptide and use thereof
08/08/2000US6100380 Amino acid sequences; for the treatment of infections, anemias, allergies and immune defects
08/08/2000US6100379 Artificial generated amino acid sequences; for the development of diagnostic tools for the detection of connective tissue degradation by-products
08/08/2000US6100377 Aromatically adjusted and confined amino acid sequences; for the development of more efficient synthetic polypeptides
08/08/2000US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
08/08/2000US6100236 Method and composition for treating thrombosis
08/08/2000US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
08/08/2000CA2000893C Biologically active lipoprotein and its use
08/03/2000WO2000044771A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
08/03/2000WO2000024884A3 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility
08/03/2000WO2000018921A3 Synthetic peptides having fgf receptor affinity
08/03/2000WO1999015130A3 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
08/03/2000CA2743116A1 Alpha-conotoxin peptides with a 4/7 motif
08/03/2000CA2359043A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP0554383B1 Blood coagulation protein antagonists and uses therefor
08/02/2000CN1261895A Cyclic azapeptide with angiogenic effect
08/01/2000US6096710 Collagen-like peptoid residue-containing structures
08/01/2000US6096709 Use of angiotensin II fragments and analogs thereof in tissue repair
08/01/2000US6096707 Cyclic oligo/polypeptide including an arginine-lysine-lysine-histidine sequence effective to inhibit integrin-dependent cell migration
08/01/2000US6096551 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
08/01/2000US6096512 Cloned DNA encoding a UDP-GalNAc: Polypeptide, N-acetylgalactosaminyltransferase
08/01/2000US6096315 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/01/2000CA1341070C Pulmonary surfactant protein and related polypeptide
08/01/2000CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens
07/2000
07/27/2000WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
07/27/2000WO2000043409A2 Alpha-conotoxin peptides
07/27/2000WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same
07/27/2000WO2000025814A3 Component for vaccine against serogroup b meningococci
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000CA2361138A1 Alpha-conotoxin peptides
07/27/2000CA2359633A1 Homing pro-apoptotic conjugates and methods of using same
07/26/2000EP1021202A1 Immunogenic peptides from the hpv e7 protein
07/26/2000EP1021200A1 Methods and compositions for treating rheumatoid arthritis
07/26/2000EP0904541A4 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
07/26/2000EP0821697B1 Method for preparing streptogramines
07/26/2000EP0769054B1 Immunomodulators
07/26/2000CN1261374A Isolated nona- and decapeptides which bind to HLA molecules,and the use thereof
07/26/2000CN1261281A Peptide parathyroid hormone analogs
07/26/2000CN1054857C Motilin-like polypeptides with gastrointinal motor stimulating activity
07/25/2000US6093797 Modifications of the tripeptide hormone melanocyte stimulating inhibitory factor; can cross blood-brain barrier; side effect reduction
07/25/2000US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells
07/25/2000US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor
07/25/2000US6093383 Bisamine bisthiol radiolabel binding moieties
07/25/2000CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
07/25/2000CA2049325C Peptide, immunogenic composition and vaccine or medicinal preparation; a method immunising a mammal against lhrh, and a method of improving the meat quality of pigs
07/20/2000WO2000042179A2 Complex-forming proteins
07/20/2000WO2000042069A1 Bone stimulating factor
07/20/2000WO2000042065A1 Pseudopeptide, synthesis method, reagent and applications
07/20/2000WO2000042064A1 Peptides for inhibiting hpv e6 proteins
07/20/2000WO2000042063A2 Peptides for inhibiting hbv core proteins
07/20/2000WO2000041711A1 Methods for inhibiting tumor metastasis, and peptides useful therefor
07/20/2000WO2000021981A3 TNFα BINDING PEPTIDES AND THEIR UTILIZATION FOR DETECTING, DEACTIVATING AND/OR REMOVING TNFα FROM BIOLOGICAL FLUIDS
07/20/2000WO2000020572A3 Tissue binding peptides, identification, production and utilization thereof
07/20/2000DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins